Drugs / Cilnidipine
Cilnidipine
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01838967 | Apr → Jun 2013 | — | IlDong Pharmaceutical Co Ltd | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00890279 | Jul 2009 → Jun 2010 | autosomal dominant polycystic kidney disease | Ministry of Health, Labour and Welfare, Japan | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02145104 | Jun 2014 → Jun 2016 | essential hypertension | IlDong Pharmaceutical Co Ltd | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT00541853 | Dec 2007 → Nov 2012 | autosomal dominant polycystic kidney disease | Kyorin University | Unknown | No outcome recorded |
| Phase 4 | NCT00325936 | Jul 2005 → Jun 2007 | hypertensive disorder, metabolic syndrome X | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00325637 Comparator | Jan 2005 → Jul 2007 | hypertensive disorder, ischemic stroke | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cilnidipine | “C - Cilnidipine 10mg will be administered orally only one time.” NCT01838967 ↗ |
| Known as | Atelec | ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗ |
| Known as | Cilnidipino | ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗ |
| Known as | Cinalong | ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗ |
| Known as | FRC-8653 | ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗ |
| Known as | Siscard | ChEMBL registry synonym — accepted as the source's own label CHEMBL452076 ↗ |
| Modality | Small molecule | — CHEMBL452076 ↗ |
| Route | Oral | “Cilnidipine 10\~20mg, qd, po for 4 weeks.” NCT00325637 ↗ |